Table 2.
Run | A | B | C | D | Lovastatin yielda (µg g-1 DFM) | |
---|---|---|---|---|---|---|
% Moisture content | Particle size (mm) | K2HPO4 (% v/w) | Trace ion conc. (% v/w) | Experimental | Predicted | |
1 | 60 | 0.35 | 10 | 10 | 2206 ± 51 | 2532 |
2 | 80 | 0.35 | 10 | 10 | 1743 ± 21 | 1916 |
3 | 60 | 0.7 | 10 | 10 | 1721 ± 43 | 1736 |
4 | 80 | 0.7 | 10 | 10 | 1203 ± 34 | 1353 |
5 | 60 | 0.35 | 30 | 10 | 2322 ± 51 | 2248 |
6 | 80 | 0.35 | 30 | 10 | 1633 ± 14 | 1941 |
7 | 60 | 0.7 | 30 | 10 | 989 ± 54 | 1238 |
8 | 80 | 0.7 | 30 | 10 | 1187 ± 23 | 1164 |
9 | 60 | 0.35 | 10 | 30 | 2563 ± 39 | 2632 |
10 | 80 | 0.35 | 10 | 30 | 1539 ± 45 | 1681 |
11 | 60 | 0.7 | 10 | 30 | 2076 ± 44 | 2159 |
12 | 80 | 0.7 | 10 | 30 | 1322 ± 60 | 1442 |
13 | 60 | 0.35 | 30 | 30 | 2506 ± 21 | 2747 |
14 | 80 | 0.35 | 30 | 30 | 2075±35 | 2106 |
15 | 60 | 0.7 | 30 | 30 | 2187 ± 31 | 2061 |
16 | 80 | 0.7 | 30 | 30 | 1587 ± 22 | 1652 |
17 | 50 | 0.525 | 20 | 20 | 1196 ± 47 | 1023 |
18 | 90 | 0.525 | 20 | 20 | 263 ± 21 | 262 |
19 | 70 | 0.175 | 20 | 20 | 2914 ± 54 | 2525 |
20 | 70 | 0.875 | 20 | 20 | 1324 ± 26 | 1276 |
21 | 70 | 0.525 | 0 | 20 | 3071 ± 45 | 2751 |
22 | 70 | 0.525 | 40 | 20 | 2795 ± 37 | 2678 |
23 | 70 | 0.525 | 20 | 0 | 2577 ± 17 | 2233 |
24 | 70 | 0.525 | 20 | 40 | 2914 ± 30 | 2821 |
25 | 70 | 0.525 | 20 | 20 | 2593 ± 46 | 2472 |
26 | 70 | 0.525 | 20 | 20 | 2501 ± 19 | 2472 |
27 | 70 | 0.525 | 20 | 20 | 2451 ± 61 | 2472 |
28 | 70 | 0.525 | 20 | 20 | 2435 ± 46 | 2472 |
29 | 70 | 0.525 | 20 | 20 | 2435 ± 26 | 2472 |
30 | 70 | 0.525 | 20 | 20 | 2443 ± 43 | 2472 |
Values are mean ± SD of three or more determinations